Monitoring of platinum surface contamination in seven Dutch hospital pharmacies using inductively coupled plasma mass spectrometry

International Archives of Occupational and Environmental Health

Volumn 80, Issue 8, 2007, Pages 689-699

  Brouwers, Elke E M ^a   Huitema, A D R ^a   Bakker, E N ^b   Douma, J W ^c   Schimmel, K J M ^d   van Weringh, G ^e   de Wolf, P J ^f   Schellens, J H M ^g,h   Beijnen, J H ^a,g,h  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^f Hospital Pharmacy of Haarlem   (Netherlands)

^g UTRECHT UNIVERSITY   (Netherlands)

^h ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

Hospital pharmacies; ICP MS; Platinum; Surface contamination; Validation

Indexed keywords

CARBOPLATIN; CISPLATIN; OXALIPLATIN; PLATINUM DERIVATIVE; STAINLESS STEEL;

ARTICLE; ASSAY; BUILDING; GEOGRAPHY; HOSPITAL DEPARTMENT; LAMINAR AIRFLOW; MASS SPECTROMETRY; NETHERLANDS; POLLUTION MONITORING; PROCESS OPTIMIZATION; QUANTITATIVE ANALYSIS; RELIABILITY; REPRODUCIBILITY; SAMPLING; SENSITIVITY AND SPECIFICITY; VALIDATION PROCESS;

CYTOTOXINS; ENVIRONMENTAL MONITORING; EQUIPMENT CONTAMINATION; HUMANS; MASS SPECTROMETRY; NETHERLANDS; OCCUPATIONAL EXPOSURE; PHARMACISTS; PHARMACY SERVICE, HOSPITAL; PLATINUM;

EID: 34249985737     PISSN: 03400131     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00420-007-0181-4     Document Type: Article

References (27)

1. Barefoot RR (1997) Determination of platinum at trace levels in environmental and biological samples. Environ Sci Technol 31:309-314
2. Connor TH, Sessink PJ, Harrison BR, Pretty JR, Peters BG, Alfaro RM, Bilos A, Beckmann G, Bing MR, Anderson LM, Dechristoforo R (2005) Surface contamination of chemotherapy drug vials and evaluation of new vial-cleaning techniques: Results of three studies. Am J Health Syst Pharm 62:475-484
3. Crauste-Manciet S, Sessink PJ, Ferrari S, Jomier JY, Brossard D (2005) Environmental contamination with cytotoxic drugs in healthcare using positive air pressure isolators. Ann Occup Hyg 49:619-628
4. Donner AL (1978) Possible risk of working with antineoplastic drugs in horizontal laminar flow hoods. Am J Hosp Pharm 35:900
5. Ensslin AS, Pethran A, Schierl R, Fruhmann G (1994a) Urinary platinum in hospital personnel occupationally exposed to platinum-containing antineoplastic drugs. Int Arch Occup Environ Health 65:339-342
6. Ensslin AS, Stoll Y, Pethran A, Pfaller A, Rommelt H, Fruhmann G (1994b) Biological monitoring of cyclophosphamide and ifosfamide in urine of hospital personnel occupationally exposed to cytostatic drugs. Occup Environ Med 51:229-233
7. Ensslin AS, Huber R, Pethran A, Rommelt H, Schierl R, Kulka U, Fruhmann G (1997) Biological monitoring of hospital pharmacy personnel occupationally exposed to cytostatic drugs: Urinary excretion and cytogenetics studies. Int Arch Occup Environ Health 70:205-208
8. Falck K, Grohn P, Sorsa M, Vainio H, Heinonen E, Holsti LR (1979) Mutagenicity in urine of nurses handling cytostatic drugs. Lancet 1:1250-1251
9. Fransman W, Vermeulen R, Kromhout H (2004) Occupational dermal exposure to cyclophosphamide in Dutch hospitals: A pilot study. Ann Occup Hyg 48:237-244
10. Hedmer M, Georgiadi A, Bremberg ER, Jonsson BA, Eksborg S (2005) Surface contamination of cyclophosphamide packaging and surface contamination with antineoplastic drugs in a hospital pharmacy in Sweden. Ann Occup Hyg 49:629-637
11. International Agency for Research on Cancer (IARC) (1997) Monographs on the evaluation of the carcinogenic risks of chemicals to humans: Overall evaluations of carcinogenicity. Updation of IARC monographs. vols 1-42. Lyon, France. http://www.iarc.fr
12. Leboucher G, Serratrice F, Bertholle V, Thore L, Bost M (2002) [Evaluation of platinum contamination of a hazardous drug preparation area in a hospital pharmacy]. Bull Cancer 89:949-955
13. Lustig L, Zang S, Michalke B, Schramel P, Beck W (1997) Platinum determination in nutrient plants by inductively coupled plasma mass spectrometry with special respect to the hafnium oxide interference. Fresenius J Anal Chem 357:1157-1163
14. Mason HJ, Morton J, Garfitt SJ, Iqbal S, Jones K (2003) Cytotoxic drug contamination on the outside of vials delivered to a hospital pharmacy. Ann Occup Hyg 47:681-685
15. Mason HJ, Blair S, Sams C, Jones K, Garfitt SJ, Cuschieri MJ, Baxter PJ (2005) Exposure to antineoplastic drugs in two UK hospital pharmacy units. Ann Occup Hyg 49:603-610
16. Minoia C, Turci R, Sottani C, Schiavi A, Perbellini L, Angeleri S, Draicchio F, Apostoli P (1998) Application of high performance liquid chromatography/tandem mass spectrometry in the environmental and biological monitoring of health care personnel occupationally exposed to cyclophosphamide and ifosfamide. Rapid Commun Mass Spectrom 12:1485-1493
17. Nygren O, Lundgren C (1997) Determination of platinum in workroom air and in blood and urine from nursing staff attending patients receiving cisplatin chemotherapy. Int Arch Occup Environ Health 70:209-214
18. Nygren O, Gustavsson B, Strom L, Friberg A (2002) Cisplatin contamination observed on the outside of drug vials. Ann Occup Hyg 46:555-557
19. Pethran A, Schierl R, Hauff K, Grimm CH, Boos KS, Nowak D (2003) Uptake of antineoplastic agents in pharmacy and hospital personnel. Part I: monitoring of urinary concentrations. Int Arch Occup Environ Health 76:5-10
20. Raghavan R, Burchett M, Loffredo D, Mulligan JA (2000) Low-level (PPB) determination of cisplatin in cleaning validation (rinse water) samples. II. A high-performance liquid chromatographic method. Drug Dev Ind Pharm 26:429-440
21. Schmaus G, Schierl R, Funck S (2002) Monitoring surface contamination by antineoplastic drugs using gas chromatography-mass spectrometry and voltammetry. Am J Health Syst Pharm 59:956-961
22. Schreiber C, Radon K, Pethran A, Schierl R, Hauff K, Grimm CH, Boos KS, Nowak D (2003) Uptake of antineoplastic agents in pharmacy personnel. Part II: Study of work-related risk factors. Int Arch Occup Environ Health 76:11-16
23. Sessink PJ, Van de Kerkhof MC, Anzion RB, Noordhoek J, Bos RP (1994) Environmental contamination and assessment of exposure to antineoplastic agents by determination of cyclophosphamide in urine of exposed pharmacy technicians: Is skin absorption an important exposure route? Arch Environ Health 49:165-169
24. Turci R, Sottani C, Ronchi A, Minoia C (2002) Biological monitoring of hospital personnel occupationally exposed to antineoplastic agents. Toxicol Lett 134:57-64
25. Turci R, Sottani C, Spagnoli G, Minoia C (2003) Biological and environmental monitoring of hospital personnel exposed to antineoplastic agents: A review of analytical methods. J Chromatogr B Analyt Technol Biomed Life Sci 789:169-209
26. Zeedijk M, Greijdanus B, Steenstra FB, Uges DRA (2005) Monitoring of cytostatics on the hospital ward: Measuring surface contamination of four different cytostatic drugs from one wipe sample. Eur J Hosp Pharm Sci 11:18-22
27. Ziegler E, Mason HJ, Baxter PJ (2002) Occupational exposure to cytotoxic drugs in two UK oncology wards. Occup Environ Med 59:608-612